{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:57:36Z","timestamp":1793948256322,"version":"4.8.0"},"reference-count":24,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Sports Med"],"published-print":{"date-parts":[[1997,3]]},"abstract":"<jats:p>OBJECTIVE: To identify unsupervised anabolic steroid regimens used by athletes. METHODS: 100 athletes attending four gymnasia were surveyed using an anonymous self administered questionnaire. RESULTS: Anabolic steroid doses ranged from 250 to 3200 mg per week and users combined different drugs to achieve these doses. Injectable and oral preparations were used in cycles lasting four to 12 weeks. Eighty six per cent of users admitted to the regular use of drugs other than steroids for various reasons, including additional anabolic effects, the minimisation of steroid related side effects, and withdrawal symptoms. Acne, striae, and gynaecomastia were the most commonly reported subjective side effects. CONCLUSIONS: Multiple steroids are combined in megadoses and self administered in a cyclical fashion. Polypharmacy is practised by over 80% of steroid users. Skeletal muscle hypertrophy along with acne, striae, and gynaecomastia are frequent physical signs associated with steroid use.<\/jats:p>","DOI":"10.1136\/bjsm.31.1.54","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T00:55:24Z","timestamp":1229388924000},"page":"54-58","source":"Crossref","is-referenced-by-count":126,"title":["Gym and tonic: a profile of 100 male steroid users."],"prefix":"10.1136","volume":"31","author":[{"given":"N A","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1997,3,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiological doses of testosterone on muscle size and strength in normal men","volume":"335","author":"Bhasin, S.; Storer, T.W.; Berman, N.; Callegari, C.; Clevenger, B.; Phillips, J.","year":"1996","unstructured":"Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, et al. The effects of supraphysiological doses of testosterone on muscle size and strength in normal men. N EnglJ Med 1996;335:1-7.","journal-title":"N EnglJ Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/036354658401200613","article-title":"Anabolic steroids: a review of the literature","volume":"12","author":"Haupt, H.A.; Rovere, G.D.","year":"1984","unstructured":"Haupt HA, Rovere GD. Anabolic steroids: a review of the literature. Am J Sports Med 1984;12:469-84.","journal-title":"Am J Sports Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bjsm.28.2.79","article-title":"Licit steroid use-hope for the future","volume":"28","author":"Millar, A.P.","year":"1994","unstructured":"Millar AP. Licit steroid use-hope for the future. BrJt Sports Med 1994;28:79-83.","journal-title":"BrJt Sports Med"},{"key":"ref_4","first-page":"259","article-title":"Dying to be big: a review of anabolic steroid use","volume":"26","author":"Perry, H.M.; Wright, D.; Littlepage, B.","year":"1993","unstructured":"Perry HM, Wright D, Littlepage B. Dying to be big: a review of anabolic steroid use. BrJ_ Sports Med 1993:26:259-61.","journal-title":"BrJ_ Sports Med"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1136\/bjsm.27.3.200","article-title":"Anabolic steroid use among students at a British college of technology","volume":"27","author":"Williamson, D.J.","year":"1993","unstructured":"Williamson DJ. Anabolic steroid use among students at a British college of technology. BrJ7 Sports Med 1993;27:200-1.","journal-title":"BrJ7 Sports Med"},{"key":"ref_6","first-page":"60","article-title":"The history of synthetic testosterone","volume":"272","author":"Hoberman, J.M.; Yesalis, C.E.","year":"1995","unstructured":"Hoberman JM, Yesalis CE. The history of synthetic testosterone. SciAm 1995;272:60-5.","journal-title":"SciAm"},{"key":"ref_7","article-title":"Anabolic reference guide","author":"Phillips, W.N.","year":"1991","unstructured":"Phillips WN. Anabolic reference guide, 6th ed. Golden, Colorado: Mile High Publishing, 1991.","edition":"6th ed"},{"key":"ref_8","article-title":"Underground steroid handbook","author":"Duchaine, D.","year":"1989","unstructured":"Duchaine D. Underground steroid handbook. Venice, California: HLR Technical Books, 1989."},{"key":"ref_9","author":"Grunding, P.; Bachmann, M.","year":"1996","unstructured":"Grunding P, Bachmann M. World anabolic review 1996.","journal-title":"World anabolic review"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2610001","article-title":"Multiple actions of beta adrenergic agonists on skeletal muscle and adipose tissue","volume":"261","author":"Yang, Y.T.; McElligot, M.A.","year":"1989","unstructured":"Yang YT, McElligot MA. Multiple actions of beta adrenergic agonists on skeletal muscle and adipose tissue. Biochem Jf 1989;261: 1-1 0.","journal-title":"Biochem Jf"},{"key":"ref_11","first-page":"651","article-title":"Clenbutarol, a beta adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Gun","volume":"84","author":"Maltin, C.A.; Delday, M.I.; Watson, J.S.; Heys, S.D.; Nevison, I.M.; Ritchie, I.K.","year":"1993","unstructured":"Maltin CA, Delday MI, Watson JS, Heys SD, Nevison IM, Ritchie IK, et al. Clenbutarol, a beta adrenoceptor agonist, increases relative muscle strength in orthopaedic patients. Gun Sci 1993;84:651-4.","journal-title":"Sci"},{"issue":"30","key":"ref_12","first-page":"69","article-title":"Three cases of nalbuphine hydrochloride dependence associated with anabolic steroid use","volume":"1996","author":"McBride, A.J.; Williamson, K.; Petersen, T.","unstructured":"McBride AJ, Williamson K, Petersen T. Three cases of nalbuphine hydrochloride dependence associated with anabolic steroid use. BrJt Sports Med 1996-30:69-70.","journal-title":"BrJt Sports Med"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2007-1024704","article-title":"Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in bodybuilders","volume":"12","author":"Kuipers, H.; Wijnen, J.A.; Hartgens, F.; Willems, S.M.","year":"1991","unstructured":"Kuipers H, Wijnen JA, Hartgens F, Willems SM. Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in bodybuilders. Int J Sports Med 1991;12:413-8.","journal-title":"Int J Sports Med"},{"key":"ref_14","first-page":"476","article-title":"Steroid abuse in athletes, prostatic enlargement and bladder outflow obstruction-is there a relationship?","volume":"74","author":"Wemyss-Holden, S.A.; Hamdy, F.C.; Hastie, K.J.","year":"1994","unstructured":"Wemyss-Holden SA, Hamdy FC, Hastie KJ. Steroid abuse in athletes, prostatic enlargement and bladder outflow obstruction-is there a relationship? BrJ7 Urol 1994;74:476-8."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/archpsyc.1994.03950050035004","article-title":"Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes","volume":"51","author":"Pope, H.G.; Katz, D.L.","year":"1994","unstructured":"Pope HG, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 1994;51:375-82.","journal-title":"Arch Gen Psychiatry"},{"key":"ref_16","first-page":"408","article-title":"An acute myocardial infarction occurring in an anabolic steroid user","volume":"26","author":"Huie, M.J.","year":"1994","unstructured":"Huie MJ. An acute myocardial infarction occurring in an anabolic steroid user. Med Sci Sports Exerc 1994;26:408-13.","journal-title":"Med Sci Sports Exerc"},{"key":"ref_17","first-page":"346","article-title":"Anabolic steroid abuse and cardiac death","volume":"158","author":"Kennedy, M.C.; Lawrence, C.","year":"1993","unstructured":"Kennedy MC, Lawrence C. Anabolic steroid abuse and cardiac death. Med JAust 1993;158:346-8.","journal-title":"Med JAust"},{"key":"ref_18","first-page":"1","article-title":"Anabolic steroid-induced tendon pathology: a review of the literature","volume":"23","author":"Laseter, J.T.; Russell, J.A.","year":"1991","unstructured":"Laseter JT, Russell JA. Anabolic steroid-induced tendon pathology: a review of the literature. Med Sci Sports Exerc 1991;23:1-3.","journal-title":"Med Sci Sports Exerc"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/bmj.313.7049.100","article-title":"Anabolic steroid abuse by bodybuilders and male subfertility","volume":"313","author":"Lloyd, F.H.; Powell, P.; Murdoch, A.P.","year":"1996","unstructured":"Lloyd FH, Powell P, Murdoch AP. Anabolic steroid abuse by bodybuilders and male subfertility. BMJ 1996;313: 100-1.","journal-title":"BMJ"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bjsm.28.1.60","article-title":"An unusual cause of abnormal gait","volume":"28","author":"Perry, H.M.","year":"1994","unstructured":"Perry HM. An unusual cause of abnormal gait. Br J Sports Med 1994;28:60.","journal-title":"Br J Sports Med"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1360-0443.1991.tb03101.x","article-title":"Symptoms and correlates of anabolic-androgenic steroid dependence","volume":"86","author":"Brower, K.J.; Blow, F.C.; Young, J.P.; Hill, E.M.","year":"1991","unstructured":"Brower KJ, Blow FC, Young JP, Hill EM. Symptoms and correlates of anabolic-androgenic steroid dependence. Br), Addict 1991;86:759-68.","journal-title":"Br), Addict"},{"key":"ref_22","first-page":"130","article-title":"The use of fluoxetine in depression associated with anabolic steroid withdrawal: a case series","volume":"53","author":"Malone, D.A.; Dimeff, R.J.","year":"1992","unstructured":"Malone DA, Dimeff RJ. The use of fluoxetine in depression associated with anabolic steroid withdrawal: a case series. J CGin Psychiatry 1992;53:130-2.","journal-title":"J CGin Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/0010-440X(93)90066-D","article-title":"Anorexia nervosa and \"reverse anorexia\" among 108 male bodybuilders","volume":"34","author":"Pope, H.G.; Katz, D.L.; Hudson, J.I.","year":"1993","unstructured":"Pope HG, Katz DL, Hudson JI. Anorexia nervosa and \"reverse anorexia\" among 108 male bodybuilders. Compr Psychiatry 1993;34:406-9.","journal-title":"Compr Psychiatry"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01552908","article-title":"Sexual functioning of male anabolic steroid abusers","volume":"22","author":"Moss, H.B.; Panzak, G.L.; Tarter, R.E.","year":"1993","unstructured":"Moss HB, Panzak GL, Tarter RE. Sexual functioning of male anabolic steroid abusers. Arch Sex Behav 1993;22:1-12.","journal-title":"Arch Sex Behav"}],"container-title":["British Journal of Sports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjsm.31.1.54","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T06:53:58Z","timestamp":1715669638000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjsm.bmj.com\/lookup\/doi\/10.1136\/bjsm.31.1.54"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,3]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1997,3,1]]},"published-print":{"date-parts":[[1997,3]]}},"alternative-id":["10.1136\/bjsm.31.1.54"],"URL":"https:\/\/doi.org\/10.1136\/bjsm.31.1.54","relation":{},"ISSN":["0306-3674","1473-0480"],"issn-type":[{"value":"0306-3674","type":"print"},{"value":"1473-0480","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,3]]}}}